Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Corporate Governance
Stock Information
02186.HK
0 0  (0%)
Volume：0
03-10
2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
05-28
2024
Altered Memorandum of Association and Bye-laws
Publisher：
05-25
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
04-11
2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Publisher：
03-31
2023
LURBINECTEDIN FOR INJECTION (LY01017) GRANTED PRIORITY REVIEW BY CHINA'S CDE FOR TREATING SMALL CELL LUNG CANCER
Publisher：
03-29
2023
Terms of Reference for the Environmental, Social and Governance Committee of the board of directors of the Company
Publisher：
03-29
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
08-30
2015
List of Directors and their Role and Function
Publisher：
08-30
2015
Procedures for Shareholders to Propose a Director
Publisher：
08-30
2015
Terms of Reference for Remuneration Committee
Publisher：
1
2
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Stock Information
02186.HK
Volume：0
0
0  (0%)
Corporate Governance
03-10
2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
05-28
2024
Altered Memorandum of Association and Bye-laws
05-25
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
04-11
2023
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
03-31
2023
LURBINECTEDIN FOR INJECTION (LY01017) GRANTED PRIORITY REVIEW BY CHINA'S CDE FOR TREATING SMALL CELL LUNG CANCER
03-29
2023
Terms of Reference for the Environmental, Social and Governance Committee of the board of directors of the Company
03-29
2023
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
08-30
2015
List of Directors and their Role and Function
08-30
2015
Procedures for Shareholders to Propose a Director
08-30
2015
Terms of Reference for Remuneration Committee
1
2